BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 7713835)

  • 1. Inhaled nitric oxide does not alter the longitudinal distribution of pulmonary vascular resistance.
    Lindeborg DM; Kavanagh BP; Van Meurs K; Pearl RG
    J Appl Physiol (1985); 1995 Jan; 78(1):341-8. PubMed ID: 7713835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site of pulmonary vasodilation by inhaled nitric oxide in the perfused lung.
    Rimar S; Gillis CN
    J Appl Physiol (1985); 1995 May; 78(5):1745-9. PubMed ID: 7649908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension.
    Walmrath D; Schermuly R; Pilch J; Grimminger F; Seeger W
    Eur Respir J; 1997 May; 10(5):1084-92. PubMed ID: 9163651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interacting roles of nitric oxide and ATP in the pulmonary circulation of the rat.
    Hasséssian H; Burnstock G
    Br J Pharmacol; 1995 Feb; 114(4):846-50. PubMed ID: 7773545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide regulation of TP receptor-mediated pulmonary vasoconstriction in the anesthetized, open-chest rat.
    Valentin JP; Bessac AM; Maffre M; John GW
    Eur J Pharmacol; 1996 Dec; 317(2-3):335-42. PubMed ID: 8997619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of responses to serotonin in the pulmonary vascular bed of the cat.
    McMahon TJ; Hood JS; Nossaman BD; Kadowitz PJ
    J Appl Physiol (1985); 1993 Jul; 75(1):93-102. PubMed ID: 8104177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exhaled nitric oxide in isolated pig lungs.
    Cremona G; Higenbottam T; Takao M; Hall L; Bower EA
    J Appl Physiol (1985); 1995 Jan; 78(1):59-63. PubMed ID: 7713844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
    Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
    Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in pulmonary vascular tone during exercise. Effects of nitric oxide (NO) synthase inhibition, L-arginine infusion, and NO inhalation.
    Koizumi T; Gupta R; Banerjee M; Newman JH
    J Clin Invest; 1994 Dec; 94(6):2275-82. PubMed ID: 7527429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled nitric oxide potentiates actions of adenosine but not of sodium nitroprusside in experimental pulmonary hypertension.
    Patterson KW; Deb B; Kavanagh BP; Pearl RG
    Pharmacology; 1999 May; 58(5):246-51. PubMed ID: 10087465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoconstriction increases pulmonary nitric oxide synthesis and circulating cyclic GMP.
    Wilson PS; Thompson WJ; Moore TM; Khimenko PL; Taylor AE
    J Surg Res; 1997 Jun; 70(1):75-83. PubMed ID: 9228932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of inhaled NO and inhibition of endogenous NO synthesis in oxidant-induced acute lung injury.
    Kavanagh BP; Mouchawar A; Goldsmith J; Pearl RG
    J Appl Physiol (1985); 1994 Mar; 76(3):1324-9. PubMed ID: 8005878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostacyclin aerosol and inhaled nitric oxide fail to reverse pulmonary vasoconstriction induced by thromboxane analogue in dogs.
    Welte M; Zwissler B; Habler O; Kleen M; Messmer K
    Acta Physiol Scand; 1995 Jul; 154(3):395-405. PubMed ID: 7572237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective upregulation of arterial endothelial nitric oxide synthase in pulmonary hypertension.
    Resta TC; Gonzales RJ; Dail WG; Sanders TC; Walker BR
    Am J Physiol; 1997 Feb; 272(2 Pt 2):H806-13. PubMed ID: 9124442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EDRF inhibition augments pulmonary hypertension in intact newborn lambs.
    Fineman JR; Chang R; Soifer SJ
    Am J Physiol; 1992 May; 262(5 Pt 2):H1365-71. PubMed ID: 1590440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of inhaled nitric oxide on platelet-activating factor-induced pulmonary hypertension in dogs.
    Yamada T; Yukioka H; Hayashi M; Asada A; Inoue M
    Acta Anaesthesiol Scand; 1998 Mar; 42(3):358-68. PubMed ID: 9542566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary vasodilation by inhaled nitric oxide after endothelial injury.
    Rimar S; Gillis CN
    J Appl Physiol (1985); 1992 Nov; 73(5):2179-83. PubMed ID: 1361930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of nitric oxide synthesis results in a selective increase in arterial resistance in rabbit lungs.
    Sprague RS; Stephenson AH; Dimmitt RA; Weintraub NL; Branch CA; McMurdo L; Lonigro AJ
    Pol J Pharmacol; 1994; 46(6):579-85. PubMed ID: 7620518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged pulmonary vasodilator action of inhaled nitric oxide by Zaprinast in awake lambs.
    Ichinose F; Adrie C; Hurford WE; Zapol WM
    J Appl Physiol (1985); 1995 Apr; 78(4):1288-95. PubMed ID: 7615435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled nitric oxide reveals and attenuates endothelial dysfunction after lung transplantation.
    Lindberg L; Kimblad PO; Sjöberg T; Ingemansson R; Steen S
    Ann Thorac Surg; 1996 Dec; 62(6):1639-43. PubMed ID: 8957365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.